CMS finalizes changes to the price transparency penalty, inpatient-only list and more for 2022
Medicare policies affecting price transparency, the inpatient-only list and more will take effect Jan. 1 after CMS published its 2022 final rule for hospital outpatient departments and ambulatory surgical centers.
Payment approaches to addressing health equity are seen in a new Medicare rule for kidney care
Updates to a Center for Medicare & Medicaid Innovation care model for end-stage renal disease include an equity-related bonus payment and associated changes to benchmarking.
Accountable care models will be almost universal for Medicare and Medicaid beneficiaries by 2030, CMS leaders say
A forthcoming revamp of federal value-based payment models will include features designed to encourage provider participation, CMS and CMMI leaders said.
The stakes are only growing in efforts to improve the cost effectiveness of health, CMMI’s Elizabeth Fowler says
The head of the Center for Medicare & Medicaid Innovation spoke with an HFMA audience about the importance of efforts at the federal level and beyond to improve the cost effectiveness of health.
Feb. 17-21: CMS webinars, calls and deadlines are among upcoming healthcare finance events
A complete listing of healthcare finance-related hearings, conferences, webinars, public forums and deadlines for the week of Feb. 17.
Jan. 13-17: MedPAC policy meeting is among upcoming healthcare finance events
A complete listing of healthcare finance-related hearings, conferences, webinars, public forums and deadlines for the week of Jan. 13.
Evolving approach to federal value-based payment models will emphasize equity, affordability
Leaders with CMS and the Center for Medicare & Medicaid Innovation have published a rough blueprint of the future of value-based payment at the federal level.
Hospital care at home signifies an important innovation in acute care delivery
Although the CMS Acute Hospital Care at Home program is still early in its development in the U.S., early adopters show evidence of the program’s exciting promise, including positive impacts on health outcomes, an improved patient and provider experience, reduced cost of care and overall healthcare savings.
Moving a 340B covered entity’s pharmacy enterprise to an LLC may prove beneficial, but it requires a feasibility study
University of Utah Hospitals and Clinics (UUHC) in Salt Lake City performed research to assess the feasibility of moving its 340B covered-entity pharmacy enterprise to a Limited Liability Corporation (LLC), with a focus on risks that should be factored into the decision. Other organizations that are considering such a move could benefit from adopting UUHC’s assessment approach.
Newer payment models should be part of holistic transformation efforts, CMS deputy administrator says
Healthcare industry stakeholders can expect a new approach to how federal payment models are formulated, as a newly released rule for Medicare coverage of kidney care illustrates.